FindTrial
Sign In

Survey on a drug helpful in childbirth.

Oxytocin Use in Caesarean Section Among Anaesthesiologists in India - A Survey Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027273
Enrollment
302
Registered
2020-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Navneh Samagh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Data will be collected from various practising anaesthesiologists with more than 3 years of experience in anaesthesia in India. A questionnaire (attached below) containing questions on the various aspects of the use of oxytocin and other uterotonics will be sent to all qualified using various anesthesia social media groups.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to see the variation in doses of oxytocin used during cesarean section in India.Timepoint: 6 months—

Secondary

MeasureTime frame
The secondary objective is to see the difference in practices in patients undergoing elective vs intrapartum (emergency) caesarean section.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Navneh Samagh

All India Institute of Medical Sciences, Bathinda

navnehsamagh@gmail.com01642867437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026